bpc 157 peptide and tb 500 BPC-157 vs TB-500: Recovery Comparison BPC-157 vs. TB-500: What Patients

Each bottle contains .9% Benzyl Alcohol, .9%NaCl, 3% Glycerine

At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity

What About "Clinical Trials" and "Expanded Access"

This delivery method allows investigators to evaluate distribution patterns and uptake efficiency in controlled experimental models